Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine

This study has been completed.
Vernalis (R&D) Ltd
Information provided by:
Endo Pharmaceuticals Identifier:
First received: March 24, 2008
Last updated: June 13, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2002
  Primary Completion Date: June 2002 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):